LIBRECOR
Live / Applied — First extension granted (statement of use) (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 18 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98655261
- Mark type
- Stylized text
- Filed
- 18 Jul 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- MICHAEL A MARRERO
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of high cholesterol, excluding pharmaceutical preparations for the prevention of diabetes, diabetes management, and/or for use in connection with managing glucose and ketone levels; Pharmaceutical preparations for the treatment of high cholesterol, excluding pharmaceutical preparations for the prevention of diabetes, diabetes management, and/or for use in connection with managing glucose and ketone levels
Owner
- LIB THERAPEUTICS, INC., CINCINNATI, OH, US
- LIB THERAPEUTICS, INC., CINCINNATI, OH, US
- LIB Therapeutics, LLC, Cincinnati, OH, US
Prosecution history
- 24 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Mar 2026 — SOU EXTENSION 1 GRANTED
- 23 Mar 2026 — SOU EXTENSION 1 FILED
- 23 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Aug 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 28 Aug 2025 — OPPOSITION TERMINATED NO. 999999
- 28 Aug 2025 — OPPOSITION DISMISSED NO. 999999
- 04 Jun 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 04 Jun 2025 — OPPOSITION INSTITUTED NO. 999999
- 06 Mar 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION
- 29 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER